SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Dec 16, 2016

Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Dec. 16, 2016 · CIK: 0001585608 · Accession: 0001104659-16-162574

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-214956

Date
December 16, 2016
Author
Assistant Director
Form
CORRESP
Company
Jaguar Health, Inc. (JAGX) (CIK 0001585608)

Letter

Re: Jaguar Animal Health, Inc. Registration Statement on Form S-1 File No. 333-214956

December 16, 2016

Via Email and EDGAR

Suzanne Hayes Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549

Ladies and Gentlemen:

Jaguar Animal Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on December 19, 2016, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable.

Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.

Very truly yours,
Jaguar Animal Health, Inc.

Show Raw Text
CORRESP
1
filename1.htm

December 16, 2016

Via Email and EDGAR

Suzanne Hayes
 Assistant Director
 U.S. Securities and Exchange Commission
 100 F Street, N.E.
 Washington, D.C. 20549

Re:                             Jaguar Animal Health, Inc.
 Registration Statement on Form S-1
 File No. 333-214956

Ladies and Gentlemen:

Jaguar Animal Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission (the “Commission”) on December 19, 2016, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable.

Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.

Very truly yours,

Jaguar Animal Health, Inc.

/s/ Lisa A. Conte

Lisa A. Conte

Chief Executive Officer   and President

Jaguar Animal Health, Inc. ·  201 Mission Street, Suite 2375 · San Francisco, CA 94105

Tel: +1 (415) 371-8300  · Fax: +1 (415) 371-8311  · www.jaguaranimalhealth.com